Hemi-ablative low-dose-rate prostate brachytherapy for unilateral localised prostate cancer
Author:
Affiliation:
1. Stokes Centre for Urology; Guildford UK
Funder
Royal Surrey County NHS Foundation Trust
the Prostate Cancer Project, an NHS charity
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14948/fullpdf
Reference30 articles.
1. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study;Ahmed;Lancet,2017
2. MRI-Targeted or standard biopsy for prostate-cancer diagnosis;Kasivisvanathan;N Engl J Med,2018
3. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group;Grimm;BJU Int,2012
4. Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: the Memorial Sloan-Kettering Cancer Center experience;Zelefsky;Brachytherapy,2012
5. 15-year cause specific and all-cause survival following brachytherapy for prostate cancer: negative impact of long-term hormonal therapy;Stone;J Urol,2014
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Monitoring prostate cancer after low‐dose‐rate hemigland brachytherapy with delta‐radiomics of diffusion‐weighted magnetic resonance imaging;International Journal of Urology;2024-09-11
2. The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations;European Urology;2024-05
3. A unified strategy to focal brachytherapy incorporating transperineal biopsy, image fusion, and real-time implantation with and without rectal spacer simulated in prostate phantoms;Journal of Contemporary Brachytherapy;2024
4. Is hemi-gland focal LDR brachytherapy as effective as whole-gland treatment for unilateral prostate cancer?;Brachytherapy;2022-11
5. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years?;European Urology;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3